Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7219-23.

T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis.

Desquenne-Clark L, Esch TR, Otvos L Jr, Heber-Katz E.

Source

Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.

Abstract

It has previously been reported that synthetic peptides corresponding to sequences derived from T-cell receptor variable regions identified as dominant in the T-cell-mediated autoimmune disease experimental allergic encephalomyelitis in both the mouse and the rat can down-regulate disease in Lewis rats. In contrast to these results, we have found that immunization of Lewis rats with such peptides in complete Freund's adjuvant prior to induction of experimental allergic encephalomyelitis with myelin basic protein leads to responses ranging from profound disease enhancement to lack of disease. In some cases, enhanced disease was followed by a prolonged neurologic deficit that resembles multiple sclerosis more closely than does acute experimental allergic encephalomyelitis. These findings, on the one hand, support previous results showing T-cell receptor peptide-induced modulation of the disease experimental allergic encephalomyelitis and, on the other, indicate that such immunization is not a reliable method for inducing suppression of encephalitogenic effector cells.

PMID:: 1714594; [PubMed - indexed for MEDLINE]
PMCID:: PMC52265

Free PMC Article

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Related Immune Epitope Information - Immune Epitope Database and Analysis Resource

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. [Int Immunol. 1998]
Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H. Int Immunol. 1998 Aug; 10(8):1139-48.
Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis. [J Immunol. 1990]
Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis.
Hashim GA, Vandenbark AA, Galang AB, Diamanduros T, Carvalho E, Srinivasan J, Jones R, Vainiene M, Morrison WJ, Offner H. J Immunol. 1990 Jun 15; 144(12):4621-7.
Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. [J Exp Med. 1995]
Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A, Simmonds S, Huitinga I, Mason D. J Exp Med. 1995 Aug 1; 182(2):335-44.
Review Role of antibodies in T cell-mediated experimental allergic encephalomyelitis. [J Neurosci Res. 1988]
Review Role of antibodies in T cell-mediated experimental allergic encephalomyelitis.
Hashim GA, Day ED. J Neurosci Res. 1988 Sep; 21(1):1-5.
Review T cell receptor peptide therapy for autoimmune disease. [J Autoimmun. 1992]
Review T cell receptor peptide therapy for autoimmune disease.
Vandenbark AA, Chou YK, Bourdette DN, Whitham R, Hashim GA, Offner H. J Autoimmun. 1992 Apr; 5 Suppl A:83-92.

See reviews... See all...

Cited by 4 PubMed Central articles

Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. [J Immune Based Ther Vaccines. ...]
Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.
Musselli C, Daverio-Zanetti S, Zanetti M. J Immune Based Ther Vaccines. 2004 Nov 12; 2(1):9. Epub 2004 Nov 12.
Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization. [J Exp Med. 1996]
Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization.
McKeever U, Khandekar S, Newcomb J, Naylor J, Gregory P, Brauer P, Jesson M, Bettencourt B, Burke E, Alderson A, et al. J Exp Med. 1996 Nov 1; 184(5):1755-68.
Self tolerance to T cell receptor V beta sequences. [J Exp Med. 1995]
Self tolerance to T cell receptor V beta sequences.
Falcioni F, Vidović D, Ward ES, Bolin D, Singh G, Shah H, Ober B, Nagy ZA. J Exp Med. 1995 Jul 1; 182(1):249-54.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

T-cell receptor peptide immunization leads to enhanced and chronic experimental ...
T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis.
Proc Natl Acad Sci U S A. 1991 Aug 15 ;88(16):7219-23.

PubMed
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer ...
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
Vaccine. 2007 Jan 26 ;25(7):1204-13. Epub 2006 Oct 17 .

PubMed
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human...
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
Proc Natl Acad Sci U S A. 1991 Apr 15 ;88(8):3088-91.

PubMed
Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy i...
Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.
J Immune Based Ther Vaccines. 2006 Oct 23 ;4:5.

PubMed
Antibodies specific for VB8 receptor peptide suppress experimental autoimmune en...
Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis.
J Immunol. 1990 Jun 15 ;144(12):4621-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information